Compare SABS & PSHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SABS | PSHG |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 344.8M | 21.1M |
| IPO Year | 2020 | 2010 |
| Metric | SABS | PSHG |
|---|---|---|
| Price | $3.41 | $1.74 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $10.75 | N/A |
| AVG Volume (30 Days) | ★ 274.2K | 46.7K |
| Earning Date | 05-12-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 78.53 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $49.57 |
| Revenue Next Year | N/A | $2.73 |
| P/E Ratio | ★ N/A | $1.59 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.85 | $1.61 |
| 52 Week High | $5.15 | $2.58 |
| Indicator | SABS | PSHG |
|---|---|---|
| Relative Strength Index (RSI) | 36.38 | 50.66 |
| Support Level | $3.38 | $1.71 |
| Resistance Level | $4.02 | $1.77 |
| Average True Range (ATR) | 0.13 | 0.07 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 13.43 | 62.99 |
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.
Performance Shipping Inc is a shipping company. The company is a provider of shipping transportation services through the ownership of tanker vessels. The company's vessels are employed on time charters with liner companies carrying container vessels and cargo along various shipping routes. It owns and operates Aframax and Suezmax tanker vessels.